Learn more

AVENTIS PHARMA GMBH

Overview
  • Total Patents
    4,220
About

AVENTIS PHARMA GMBH has a total of 4,220 patent applications. Its first patent ever was published in 1975. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are VERTEKS FARMAS JUTIKALZ INKORP, IFM THERAPEUTICS INC and CHROMA THERAPEUTICS LTD.

Patent filings per year

Chart showing AVENTIS PHARMA GMBHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Glombik Heiner 292
#2 Jaehne Gerhard 289
#3 Lang Hans-Jochen 267
#4 Kleemann Heinz-Werner 246
#5 Frick Wendelin 214
#6 Schaefer Hans-Ludwig 208
#7 Bickel Martin 198
#8 Kramer Werner 176
#9 Schoenafinger Karl 172
#10 Gossel Matthias 170

Latest patents

Publication Filing date Title
US2005250676A1 Method of activating insulin receptor substrate-2 to stimulate insulin production
US2005255071A1 Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors
US2005261341A1 Novel processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
CA2496690A1 A novel c. elegans p21-activated kinase (pak) gene and associated loss-of-function phenotypes that facilitate screening for small molecule modulators of pak activity in the nematode, caenorhabditis elegans
CA2496985A1 Method for the identification of a risk for a thrombogenic disorder by determining the tafi -ile347 polymorphism
JP2005287503A Method for identifying risk for thrombogenic disorder by determining tafi-ile347 polymorphism
US2005143347A1 Medicinal lipolysis of accumulations of fat
IL165641D0 Fluorinated cycloalkyl-derivatised benzoylguanidines process for their preparation their use as a medicament and medicament containing them
IL165622D0 HTS-capable and assay
ZA200409380B Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compunds and use thereof.
US2005175601A1 Use of LIMK-1, its analogues and ligands for the production of a medicament against a thrombus formation or blood clotting disease
US2005124666A1 Pentafluorosulfanylbenzoylguanidines, process for their preparation, use as a medicament or diagnostic aid, and medicament comprising same
US2005089555A1 Medicinal targeted local lipolysis
US2005054673A1 Combination of phenylcarboxylic acid amides with beta-adrenoreceptor blockers and their use for the treatment of atrial arrhythmias
US2005112701A1 Test system for the identification of APJ receptor ligands
US2005019914A1 Perfusion process for producing erythropoietin
US2005014182A1 Use of calpain for identifying compounds that modulate pain
US2005092941A1 Method and device for the quantitative analysis of solutions and dispersions by means of near infrared spectroscopy
US2005032695A1 Method for alleviating pain using protein associated with MYC and related compounds, and assays for identifying such compounds
EP1598348A1 Novel pyridazinone derivatives as inhibitors of CDK2